|
|
||||||||
NIBS-Neuroscience Program and Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-2520
| |
ABSTRACT |
|---|
|
|
|---|
We have used the anorexia shown by rats given hypertonic saline to drink to investigate central mechanisms that can inhibit feeding. Rats dehydrated in this manner for 3 or 5 days showed a severe attenuation of the compensatory feeding observed after an overnight fast compared with control euhydrated rats or rats whose food was restricted to match the intake of anorexic rats. Food intake after injections of 2-deoxy-D-glucose (2-DG) was also significantly decreased in dehydrated animals compared with that after a 2-DG injection given before dehydration. However, all the dehydrated animals demonstrated a robust eating response after water was returned whether they had received injection of 2-DG or vehicle. Despite a profound reduction in 2-DG-induced feeding, other glucoregulatory responses to 2-DG remained intact in dehydrated animals. After 2-DG injection, corticosterone secretion and blood glucose were significantly elevated from preinjection values whether or not animals were dehydrated. Thus the mechanisms responsible for anorexia in dehydrated animals specifically target stimulatory feeding pathways but leave intact other counterregulatory glucometabolic motor events.
corticosterone; plasma glucose; 2-deoxy-D-glucose; overnight fast; dehydration
| |
INTRODUCTION |
|---|
|
|
|---|
ANOREXIA, THE LOSS OF APPETITE for food, is evoked by many different mechanisms. Although it is a significant complication to a variety of clinical pathologies, the underlying neural mechanisms responsible for anorexia are largely unknown. To investigate these neural substrates, we have taken advantage of a simple way to stimulate anorexia in animals. When their drinking water is replaced with hypertonic saline, rats not only become progressively dehydrated, they also exhibit a profound anorexia, which is maintained until access to water is restored (50). In an effort to conserve water and limit the addition of osmoles to an already compromised fluid compartment, dehydration implements a series of adaptive responses that target gastrointestinal function. Thus salivation, gut motility, and spontaneous circadian-driven feeding are reduced in an attempt to resolve or minimize fluid perturbations at the expense of energy balance (11, 17, 54). In this way, dehydration-anorexia offers a useful paradigm for investigating how the normal compensatory mechanisms used to trigger feeding during negative energy balance can be inhibited.
We previously demonstrated that dehydrated animals and animals that are food restricted to match the intake of anorexic rats show the same attributes of negative energy balance (54). These include body weight loss, diminished circulating leptin and insulin, and increased blood glucocorticoid concentrations and neuropeptide Y (NPY) gene expression in the arcuate nucleus of the hypothalamus (ARH). Normally, these neural and endocrine processes stimulate compensatory feeding mechanisms aimed at increasing caloric intake to match expenditure. In this way, weight loss triggers hunger to restore body energy stores through food intake. Elevated glucocorticoids and decreased insulin levels can independently stimulate food intake (4, 44), whereas falling plasma leptin levels after starvation (9, 19) or the deficiency of leptin in ob/ob mice (8) stimulates eating.
Feeding behavior is mediated in certain circumstances by the increased activity of those NPY-producing neurons in the ARH (1, 37) that express leptin receptors (6) and project to the paraventricular nucleus of the hypothalamus (PVH) and the lateral hypothalamic area (LHA) (6, 15). NPY injections into the PVH or LHA elicit robust feeding (26, 45, 46), whereas chronic infusions of NPY lead to hyperphagia and obesity (57). On the basis of their neuropeptide and endocrine profile, we have proposed that, in dehydrated-anorexic animals, some component of these NPY-mediated compensatory mechanisms is inhibited until released by subsequent water intake (52).
The present study was designed to determine whether dehydrated-anorexic rats show reduced feeding responses to two challenges that invoke feeding responses that are believed to involve NPY-mediated mechanisms: 2-deoxy-D-glucose (2-DG) and overnight starvation. NPY appears to be a key mediator of fasting-induced hyperphagia, in that food deprivation increases NPY mRNA in the ARH (9) and elevates NPY levels and release in the PVH (24, 37, 56). 2-DG is a glucose analog that leads to cytoglucopenia by competitively inhibiting glucose utilization. Evidence implicates NPY in the feeding response that follows central or peripheral administration of 2-DG (2, 21, 22, 27). 2-DG feeding is mediated by central catecholamine neurons (31, 33, 34), which colocalize NPY and project to the PVH (40). Immunoneutralization of NPY in the PVH impairs 2-DG feeding (22), whereas 2-DG-induced glucoprivation increases Fos expression in ARH NPY neurons (27).
2-DG offers a further advantage as an experimental tool for delineating the neural circuits underlying anorexia, because, in addition to stimulating feeding, it rapidly elicits two other motor responses: sympathetic activation of epinephrine secretion from the adrenal medulla, which leads to hyperglycemia (41), and corticosterone secretion from the adrenal cortex (55), which is driven by increased activation of neuroendocrine corticotropin-releasing hormone (CRH) neurons in the PVH. Together, these behavioral, autonomic, and neuroendocrine motor events serve to replenish and redistribute metabolic fuels. Examining how other nonbehavioral motor control systems function during dehydration should provide a broader view of how adaptive neural mechanisms function in anorexia.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals and Procedures
Adult male Sprague-Dawley rats weighing 235-260 g were obtained from Harlan Laboratories and housed in suspended Plexiglas cages with sanitized wood chips. They were maintained in a temperature-controlled room on a 12:12-h light-dark schedule with lights on at 0600. Rats were provided continuous access to food (Teklad rodent diet 8604) and water throughout the experiment, except where stated. In some animals, drinking water was replaced with 2.5% saline solution for up to 5 days; in others, the amount of food available was restricted to match that eaten by dehydrated animals (54). We previously showed that 5 days of drinking hypertonic saline increases plasma osmolality by ~6% (53, 54). Body weights and nocturnal food intake were measured daily throughout the experiment. All procedures have been approved by the local institutional animal care and use committee.Surgical Procedures
Rats were handled daily for ~4 days before any surgical intervention and daily thereafter. On the 4th day after arrival, rats designated for 2-DG injections were anesthetized with an injection (100 µl/kg im) of a 50% solution of ketamine (100 mg/ml) plus xylazine (20 mg/ml), and sterile intra-atrial catheters were inserted by way of the external jugular vein. Catheters were threaded subcutaneously to the dorsal surface, exteriorized between the scapulae, and then sutured in place. Catheters were flushed daily with sterile heparinized 0.9% saline. Animals were allowed to recover to presurgical weight before further manipulation. Only rats with stable weight gains and consistent nocturnal intakes were included in the study.Overnight Starvation
Five groups of animals were used in this experiment. Food intakes were measured in all groups for 3 days before testing. Drinking water was replaced in two groups with 2.5% saline for 3 (n = 5) or 5 days (n = 5). Body weights and food intake were then measured twice daily between 0800 and 0900 and between 1600 and 1700. Food was removed from all cages at 1700 on the evening of the final night of saline. On the following morning at 0800, a measured amount of food was returned, and the food remaining in the cage was measured to the nearest 0.1 g each hour for a total of 4 h. At the conclusion of the feeding test, saline was replaced with drinking water, and food intake was measured after a further hour.A food restriction schedule was provided for two other groups of animals maintained on drinking water. Animals were weight matched to animals dehydrated for 3 (n = 5) or 5 days (n = 5). They were then given an amount of food at the beginning of each light and dark period equal to that eaten by the dehydrated animals (54). The amount of food was calculated for each rat as a percentage of the food eaten per 100 g of mean body weight (for 2 days before beginning the food restriction). On the evening of the 2nd or 4th day of food restriction, food was removed completely. Food was returned to animals on the following morning, and intake was measured each hour for the next 4 h. A fifth group of euhydrated animals was allowed continuous access to food (n = 5) and water. Food intake was measured in this group for 4 h on the morning after an overnight fast.
Responses to 2-DG
Four experiments were performed to determine the effect of dehydration on the responses to 2-DG. In experiment 1, a dose-feeding response curve was established for 2-DG. In experiment 2, the effect of two doses of 2-DG given 7 days apart was determined to test the validity of using each animal as its own control before and during dehydration. In experiment 3, the effects of dehydration on feeding responses to 2-DG were determined. In experiment 4, the effects of dehydration on the plasma glucose and corticosterone responses to 2-DG were measured.All feeding tests were conducted between 0800 and 1300 as follows. At the beginning of the experiment, all food and sawdust were removed from the cages, the animals were weighed, and a measured amount of food was placed in the test cage for ~1 h. Equal volumetric doses of vehicle or 0.1 ml/kg 2-DG were then injected into the jugular catheter. Some rats in experiments 3 and 4 were given a subcutaneous 2-DG injection because of blocked jugular catheters. There was no significant difference in response between catheter and subcutaneous injections, so these data were pooled. After the injection, food consumption was measured by weighing the food remaining in each cage to the nearest 0.1 g each hour for the next 4 h.
Experiment 1. To establish appropriate doses of 2-DG for investigating the effects of dehydration on the feeding response to 2-DG, animals maintained with continuous access to water were injected with vehicle (0.9% saline) or one of four doses of 2-DG: 50 mg/kg (n = 5), 100 mg/kg (n = 4), 200 mg/kg (n = 5), and 250 mg/kg (n = 6). Food intake was then measured as described above.
Experiment 2. One group of animals (n = 5) was tested three times over the next 9 days for food intake after injections of vehicle or 2-DG. On day 1, vehicle injections were given to measure baseline food consumption in the test cage. On the following day, each animal was injected with 200 mg/kg 2-DG. Food intake was again measured on day 9 after an injection of 200 mg/kg 2-DG.
Experiment 3. Rats (n = 28) were divided into three groups and tested three times over the next 9 days for food intake after injection of vehicle or 2-DG. On day 1, all animals were injected with vehicle to establish baseline food consumption in the test cage. On the following day (day 2), each animal was injected with vehicle or 200 or 250 mg/kg 2-DG. On day 4, drinking water was replaced with 2.5% saline. Food intake was again measured on day 9, the 5th day of dehydration after injection of vehicle or 200 or 250 mg/kg 2-DG. Each animal received the same treatment on days 2 and 9. At the conclusion of the 4-h feeding test, drinking water was returned to all dehydrated animals, and food intake was measured during the following hour.
Experiment 4. The design of experiment 4 was virtually identical to that of experiment 3, except blood samples were taken from the jugular catheter for plasma glucose and corticosterone determinations. Animals were tested three times after equal volumetric injections of 0.9% saline vehicle or 0.1 ml/kg 2-DG. Venous blood samples (150 µl) were collected from the jugular catheters of all animals immediately before and 15, 30, 60, and 120 min after injection. Food was removed for 2 h before baseline blood collection and was not returned until after the final blood sample.
On day 1, all animals were injected with vehicle to determine baseline responses; on day 3, animals were injected intra-atrially with vehicle (n = 4) or 200 mg/kg 2-DG (n = 8). Drinking water was replaced with 2.5% saline at 1200 on the following day. On the morning of the 5th day of dehydration, rats were injected with vehicle or 200 mg/kg 2-DG. Drinking water and food were replaced at the conclusion of the blood sampling. Only animals that exhibited a feeding response of >3 g to drinking water were included in the study. Blood samples were immediately placed on ice and centrifuged, plasma was removed, and the samples were stored at 20°C until assayed. Plasma glucose concentration was assayed using an autoanalyzer (model 2700, Yellow Springs Instruments, Yellow Springs, OH). Plasma corticosterone concentrations were determined by double-antibody radioimmunoassay (48) using a commercially available kit (ICN Pharmaceuticals). All samples were assayed in duplicate in single assays. Internal controls were within appropriate ranges.Statistics
Values are means ± SE. Changes in body weight during dehydration, food intake suppression, food intake after overnight starvation, and amount eaten after return of water were compared between groups using one-way ANOVA. For analysis of plasma glucose and corticosterone responses, incremental increases were calculated for each animal by subtracting the maximum concentration attained from the preinjection value. Baseline euhydration tests were compared with euhydration 2-DG tests in experimental animals using ANOVA with repeated measures at each time point. Data from euhydrated and dehydrated animals were compared using a 2 × 2 repeated-measure ANOVA. Bonferrroni's multiple comparison test was used to measure individual differences. The critical level for significance was set at P < 0.05 for all comparisons.| |
RESULTS |
|---|
|
|
|---|
Feeding Responses to Overnight Starvation
Overnight starvation elicited significantly different amounts of compensatory feeding in dehydrated, food-restricted, and ad libitum-fed groups {at hour 4; F[df(4,25)] = 45.92, P < 0.001}. Figure 1A shows that the amount of food eaten after 4 h by 5-day food-restricted animals was significantly greater than that consumed by ad libitum-fed animals (P < 0.05). However, both groups of dehydrated animals ate significantly less after overnight starvation than either food-restricted or ad libitum-fed animals, with the animals that had been dehydrated for 5 days eating significantly less than those dehydrated for 3 days (P < 0.01). This represented a 60% and 80% reduction compared with the ad libitum-fed euhydrated group (Fig. 1B). However, all dehydrated animals displayed a robust eating response during the hour after access to drinking water was restored (Fig. 1A); the size of the response was not significantly different between the two dehydrated groups.
|
Feeding Responses to 2-DG
Changes in body weight over the course of the feeding tests are shown in Table 1. There was no significant difference in rate of weight gain among the animals in the three treatment groups before or during the testing period. At the end of dehydration, rats in each treatment group lost a similar amount of body weight and exhibited equivalent anorexia (Table 1).
|
Experiment 1
Figure 2 shows the amount of food eaten after injection of increasing doses of 2-DG. 2-DG at 50 or 100 mg/kg elicited a feeding response that was not different from the response to vehicle at all time points except hour 4, when the response to 100 mg/kg 2-DG was significantly greater (P < 0.05) than the response to vehicle or 50 mg/kg 2-DG (Fig. 2B). Animals treated with 200 or 250 mg/kg 2-DG ate significantly more than animals treated with vehicle at all times (P < 0.01). Feeding responses to vehicle and 50 mg/kg 2-DG were indistinguishable. On the basis of the results of this experiment, 200 or 250 mg/kg 2-DG was used to test the effects of dehydration on feeding responses in subsequent experiments.
|
Experiment 2
In euhydrated animals given two injections of 200 mg/kg 2-DG separated by 7 days, the response to the second injection was indistinguishable from the response to the first injection (Fig. 3). One-way repeated-measure ANOVA indicated a significant effect of 2-DG on food intake {F[df(2,12)] = 16.33, P < 0.001}. The first and second doses of 2-DG elicited significantly more food intake than vehicle at all time points (P < 0.01). However, the amount of food intake after the first injection was not significantly different from that after the second injection at any time.
|
Experiment 3
Injection of vehicle did not elicit a significant eating response in any of the three groups of animals (Fig. 4A), but after administration of 200 or 250 mg/kg 2-DG, these animals ate significantly more {F[df(2,37)] = 48.33, P < 0.001; Fig. 4B}. Figure 4C shows that dehydration significantly reduced the ability of 2-DG to elicit food intake. Two-way repeated-measure ANOVA revealed a main effect of dehydration {F[df(2,25)]= 44.25, P < 0.001} and an interaction effect between 2-DG and dehydration {F[df(2,25)] = 12.3, P < 0.001}. Finally, all dehydrated animals ate similar amounts of food when drinking water was returned at the end of the 2-DG-feeding test, whether they were injected with vehicle or one of the two doses of 2-DG 4 h previously (Fig. 4D).
|
Experiment 4
Effects of dehydration on responses of plasma glucose
concentrations to 2-DG.
Plasma glucose results are presented in Table
2 and Fig.
5. Vehicle injections did not
significantly increase plasma glucose concentrations in any treatment
group on day 1 (Fig. 5A). On day 3,
animals were injected with vehicle or 200 mg/kg 2-DG (Fig. 5B). There was no significant response to vehicle, but 2-DG
elicited a significant increase in plasma glucose from preinjection
values {F[df(4,35)] = 13.25, P < 0.001}. On day 9, preinjection plasma glucose
concentrations were not different from preinjection values on
days 1 and 3 (Table 2). After injection of
vehicle or 2-DG, mean plasma glucose concentrations in dehydrated
animals were again unaffected by vehicle injection but were
significantly increased from preinjection values by 2-DG
{F[df(4,33)] = 9.90, P < 0.001; Fig.
5C}.
|
|
Effects of DE on responses of plasma corticosterone concentrations
to 2-DG.
Corticosterone responses to vehicle or 2-DG are illustrated in Table 2
and Fig. 6. Vehicle injections did not
significantly increase plasma corticosterone concentrations from
preinjection values in any treatment group on days 1, 3, and
9 (Fig. 6A). However, 2-DG injections
significantly increased plasma corticosterone concentrations on
day 3 in euhydrated animals {F[df(4,35)] = 9.61, P < 0.001; Fig. 6B}. After 5 days
of dehydration on day 9, preinjection levels of
corticosterone were significantly elevated from those measured on
day 3 {F[df(1,10)] = 6.8, P < 0.05; Table 2}. However, 2-DG injections still
significantly increased plasma corticosterone concentrations from
preinjection values in dehydrated animals {F[df(4,33)] = 3.95, P < 0.01; Fig.
6C}.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our present results demonstrate two points regarding the control of energy balance in dehydrated-anorexic rats. First, normal plasma glucose concentrations are maintained during dehydration-anorexia, presumably because metabolism is now biased toward increased glycogenolysis and lipolysis. This observation, taken together with the fact that dehydrated-anorexic and paired-food-restricted animals have virtually identical endocrine and neuropeptidergic responses to negative energy balance (54), shows that dehydrated-anorexic animals maintain a normal metabolic response to reduced food intake. Of course, the critical difference between food-restricted and dehydrated-anorexic animals is the decreased drive to eat in the latter.
Second, we show that dehydration for as little as 3 days results in a severe attenuation of the compensatory food intake that normally occurs after an overnight fast. Dehydrated animals also eat less in response to doses of 2-DG that elicit feeding in the same rats before dehydration and have been shown by others to produce eating (35, 43). These observations are consistent with a previous study showing that 2-DG-induced food intake is attenuated in water-deprived rats (49). Dehydrated animals, therefore, do not seek to repair an actual (from overnight starvation) or a perceived (from 2-DG) caloric deficit until after access to water has been restored. At this point, dehydrated-anorexic animals reliably begin robust compensatory feeding within 10 min after return of drinking water (50). This rapid eating response clearly demonstrates that dehydrated animals will eat with appropriate stimulation and that the mechanisms responsible for inhibiting feeding to a variety of stimuli are quickly counteracted by drinking water. The mechanisms responsible for the reversal of this anorexia are unknown.
2-DG-induced glucoprivation rapidly elicits a triad of compensatory motor responses aimed at mobilizing glucose stores and replenishing energy supplies: increased secretion of epinephrine to produce hyperglycemia, glucocorticoid release, and feeding. These complementary processes are activated more or less simultaneously and promote glucose delivery to the brain. However, the fact that under certain circumstances they can be uncoupled demonstrates that their control mechanisms are not tightly linked. For example, phlorizin and alloxan, which inhibit glucose transport and glucose oxidation, respectively, elicit eating behavior, but not hyperglycemia, when injected into the fourth ventricle (18, 36). Similarly, area postrema lesions impair feeding after 2-DG administration but leave intact the hyperglycemic and the corticosterone secretory response (13). In this regard, we show that dehydrated-anorexic animals retain the ability to mount a hyperglycemic and a glucocorticoid secretory response to the same dose of 2-DG that fails to stimulate eating. Dehydration, therefore, specifically targets pathways associated with stimulating food intake, whereas those mechanisms responsible for neuroendocrine and sympathetic glucometabolism-related motor events are left intact.
Repeated daily 2-DG administration can impair the feeding response to 2-DG (39), possibly as a result of a chronic elevation of circulating glucocorticoids (10). In the present study, we have confirmed previous reports that dehydrated animals show increased plasma corticosterone levels in the morning (51). However, the mechanisms responsible for suppressing feeding in these animals are most likely different from those arising after repeated daily 2-DG, and three observations suggest that this suppression is probably not a consequence of these increased plasma corticosterone concentrations. First, nondehydrated control rats receiving two 2-DG challenges 7 days apart show identical feeding responses to each challenge. Second, the morning elevation in plasma corticosterone levels in dehydrated animals remains well below the peak values attained after 2-DG injection in euhydrated animals (present study; 51). Finally, unlike dehydration, repeated daily injections of 2-DG not only attenuate the feeding response, they also abolish the 2-DG-induced hyperglycemia (39).
The neural mechanisms that control feeding after glucoprivation or deprivation and are not fully understood, but the large body of data implicating NPY/catecholaminergic neurons in the hindbrain and NPY/agouti-related protein-containing neurons located in the ARH provides a framework for discussing our results with regard to the neural substrates of anorexia.
Injections of an antidopamine
-hydroxylase-saporin conjugate (D-SAP)
into the terminal regions of catecholaminergic neurons will
specifically destroy these neurons (31). Ritter and
colleagues (31, 32) recently took advantage of this
specificity to show that D-SAP injected into the PVH blocks the feeding
and corticosterone responses to 2-DG but leaves intact the
hyperglycemic response. In contrast, D-SAP injected into the spinal
cord destroys catecholaminergic neurons with descending connections and
blocks the hyperglycemic response to 2-DG but leaves the feeding and
corticosterone response intact (31, 32). These data
demonstrate that different subsets of hindbrain catecholaminergic
neurons mediate the behavioral, autonomic, and neuroendocrine
components of the glucoprivic response.
We show that hyperglycemic and corticosterone responses of dehydrated-anorexic rats to 2-DG are indistinguishable from those of controls. This demonstrates that the inhibitory mechanisms in dehydrated-anorexic rats do not impact those ascending and descending catecholamine pathways that target CRH neuroendocrine neurons and mediate glucocorticoid responses or those preganglionic neurons in the spinal cord that mediate hyperglycemia. In addition, our results do not support the view that neuroendocrine CRH neurons in the PVH are involved with compensatory feeding behaviors (54); corticosterone secretion remains viable in dehydrated animals, while feeding is markedly impaired. This notion is also supported by the fact that electrolytic lesions of the PVH do not hinder glucoprivic feeding (7, 42). Collectively, these data suggest that 2-DG-induced feeding requires sets of hypothalamic neurons located outside the PVH and that these systems are potential targets for dehydration-generated inhibition.
In conclusion, we previously showed that the anorexia that develops after drinking hypertonic saline inhibits spontaneous nocturnal feeding (50). The present study shows that this anorexia also involves an inhibition of two other types of feeding: compensatory feeding in response to overnight starvation and the feeding that usually follows glucoprivation. The fact that hyperglycemic and glucocorticoid responses to 2-DG remain intact in dehydrated-anorexic animals shows that dehydration specifically targets those mechanisms that control the motor events of feeding behavior, but not neuroendocrine or autonomic motor responses.
Perspectives
Evidence suggests that specific alterations to feeding mechanisms in the ARH are not responsible for dehydration-anorexia (54). Instead, dehydration-anorexia appears to be generated by activity in separate inhibitory circuits. These circuits may involve CRH, neurotensin, or oxytocin neurons found in those parts of the perifornical LHA and PVH that are targeted by plasma osmolality-sensitive rostral hypothalamic afferents (25, 28, 29, 54). In this regard, several lines of evidence support the idea that a critical component for the development of dehydration-anorexia is located within the LHA, particularly its perifornical part (LHApf). NPY-containing projections from the ARH to the LHApf are important for stimulating those types of feeding initiated by changes in the levels of circulating hormones such as leptin (15, 16). Similarly, hindbrain adrenergic and noradrenergic neurons activated by 2-DG colocalize NPY (40) and project to the PVH and LHA (14, 47). Furthermore, neurons within the LHA express NPY receptors (12, 20), and injections of NPY into the LHApf produce strong feeding responses (46). We suggest that dehydration in some way inhibits the output of those NPY-containing circuits that normally elicit food intake in response to caloric deficits. This hypothesis is consistent with certain other types of anorexia where animals exhibit a suppressed feeding response to central injections of NPY, increased NPY gene expression in ARH, and increased NPY release in the PVH (3, 5, 23, 30). However, unlike these other models of anorexia, dehydration-anorexia is rapidly and completely reversed within minutes simply by restoring access to drinking water, making it a particularly useful model with which to investigate the neural substrates of anorexia.| |
ACKNOWLEDGEMENTS |
|---|
We thank E. Ross and Dr. R. Bergman for help with the plasma glucose determinations and G. Sanchez-Watts for help with the plasma corticosterone assay.
| |
FOOTNOTES |
|---|
This work was supported by National Institute of Neurological Disorders and Stroke Grant NS-29728 and National Institute of Mental Health Grant MS-66168.
Some of these results have been presented in abstract form (38).
Address for reprint requests and other correspondence: A. G. Watts, Hedco Neuroscience Bldg., MC 2520, University of Southern California, Los Angeles, CA 90089-2520 (E-mail:watts{at}rcf.usc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
September 12, 2002;10.1152/ajpregu.00275.2002
Received 15 May 2002; accepted in final form 6 September 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ahima, RS,
Kelly J,
Elmquist JK,
and
Flier JS.
Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia.
Endocrinology
140:
4923-4931,
1999
2.
Akabayashi, A,
Zaia CT,
Silva I,
Chae HJ,
and
Leibowitz SF.
Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization.
Brain Res
621:
343-348,
1993[Web of Science][Medline].
3.
Ballinger, AB,
Williams G,
Corder R,
El-Haj T,
and
Farthing MJ.
Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat.
Clin Sci (Colch)
100:
221-229,
2001[Medline].
4.
Baskin, DG,
Figlewicz Lattemann D,
Seeley RJ,
Woods SC,
Porte D, Jr,
and
Schwartz MW.
Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight.
Brain Res
848:
114-123,
1999[Web of Science][Medline].
5.
Blanton, CA,
Horwitz BA,
Blevins JE,
Hamilton JS,
Hernandez EJ,
and
McDonald RB.
Reduced feeding response to neuropeptide Y in senescent Fischer 344 rats.
Am J Physiol Regul Integr Comp Physiol
280:
R1052-R1060,
2001
6.
Broberger, C,
Visser TJ,
Kuhar MJ,
and
Hokfelt T.
Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse.
Neuroendocrinology
70:
295-305,
1999[Web of Science][Medline].
7.
Calingasan, NY,
and
Ritter S.
Hypothalamic paraventricular nucleus lesions do not abolish glucoprivic or lipoprivic feeding.
Brain Res
595:
25-31,
1992[Web of Science][Medline].
8.
Campfield, LA,
Smith FJ,
Guisez Y,
Devos R,
and
Burn P.
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.
Science
269:
546-549,
1995
9.
Dallman, MF,
Akana SF,
Bhatnagar S,
Bell ME,
Choi S,
Chu A,
Horsley C,
Levin N,
Meijer O,
Soriano LR,
Strack AM,
and
Viau V.
Starvation: early signals, sensors, and sequelae.
Endocrinology
140:
4015-4023,
1999
10.
Davis, SN,
Shavers C,
Davis B,
and
Costa F.
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses.
J Clin Invest
100:
429-438,
1997[Web of Science][Medline].
11.
Dicker, SE,
and
Nunn J.
The role of antidiuretic hormone during water deprivation in rats.
J Physiol
136:
235-248,
1957
12.
Durkin, MM,
Walker MW,
Smith KE,
Gustafson EL,
Gerald C,
and
Branchek TA.
Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain.
Exp Neurol
165:
90-100,
2000[Web of Science][Medline].
13.
Edmonds, BK,
and
Edwards GL.
Dorsomedial hindbrain participation in glucoprivic feeding response to 2DG but not 2DG-induced hyperglycemia or activation of the HPA axis.
Brain Res
801:
21-28,
1998[Web of Science][Medline].
14.
Elias, CF,
Aschkenasi C,
Lee C,
Kelly J,
Ahima RS,
Bjorbaek C,
Flier JS,
Saper CB,
and
Elmquist JK.
Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.
Neuron
23:
775-786,
1999[Web of Science][Medline].
15.
Elias, CF,
Saper CB,
Maratos-Flier E,
Tritos NA,
Lee C,
Kelly J,
Tatro JB,
Hoffman GE,
Ollmann MM,
Barsh GS,
Sakurai T,
Yanagisawa M,
and
Elmquist JK.
Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area.
J Comp Neurol
402:
442-459,
1998[Web of Science][Medline].
16.
Elmquist, JK,
Elias CF,
and
Saper CB.
From lesions to leptin: hypothalamic control of food intake and body weight.
Neuron
22:
221-232,
1999[Web of Science][Medline].
17.
Flanagan, LM,
Dohanics J,
Verbalis JG,
and
Stricker EM.
Gastric motility and food intake in rats after lesions of hypothalamic paraventricular nucleus.
Am J Physiol Regul Integr Comp Physiol
263:
R39-R44,
1992
18.
Flynn, FW,
and
Grill HJ.
Fourth ventricular phlorizin dissociates feeding from hyperglycemia in rats.
Brain Res
341:
331-336,
1985[Web of Science][Medline].
19.
Friedman, JM,
and
Halaas JL.
Leptin and the regulation of body weight in mammals.
Nature
395:
763-770,
1998[Medline].
20.
Gerald, C,
Walker MW,
Criscione L,
Gustafson EL,
Batzl-Hartmann C,
Smith KE,
Vaysse P,
Durkin MM,
Laz TM,
Linemeyer DL,
Schaffhauser AO,
Whitebread S,
Hofbauer KG,
Taber RI,
Branchek TA,
and
Weinshank RL.
A receptor subtype involved in neuropeptide-Y-induced food intake.
Nature
382:
168-171,
1996[Medline].
21.
Giraudo, SQ,
Kim EM,
Grace MK,
Billington CJ,
and
Levine AS.
Effect of peripheral 2-DG on opioid and neuropeptide Y gene expression.
Brain Res
792:
136-140,
1998[Web of Science][Medline].
22.
He, B,
White BD,
Edwards GL,
and
Martin RJ.
Neuropeptide Y antibody attenuates 2-deoxy-D-glucose induced feeding in rats.
Brain Res
781:
348-350,
1998[Web of Science][Medline].
23.
Jensen, PB,
Blume N,
Mikkelsen JD,
Larsen PJ,
Jensen HI,
Holst JJ,
and
Madsen OD.
Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.
J Clin Invest
101:
503-510,
1998[Web of Science][Medline].
24.
Kalra, SP,
Dube MG,
Sahu A,
Phelps CP,
and
Kalra PS.
Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.
Proc Natl Acad Sci USA
88:
10931-10935,
1991
25.
Kelly, AB,
and
Watts AG.
Mediation of dehydration-induced peptidergic gene expression in the rat lateral hypothalamic area by forebrain afferent projections.
J Comp Neurol
370:
231-246,
1996[Web of Science][Medline].
26.
Leibowitz, SF,
Sladek C,
Spencer L,
and
Tempel D.
Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose.
Brain Res Bull
21:
905-912,
1988[Web of Science][Medline].
27.
Minami, S,
Kamegai J,
Sugihara H,
Suzuki N,
Higuchi H,
and
Wakabayashi I.
Central glucoprivation evoked by administration of 2-deoxy-D-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus.
Brain Res Mol Brain Res
33:
305-310,
1995[Medline].
28.
Olson, BR,
Drutarosky MD,
Stricker EM,
and
Verbalis JG.
Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake.
Endocrinology
129:
785-791,
1991
29.
Olson, BR,
Drutarosky MD,
Stricker EM,
and
Verbalis JG.
Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia.
Am J Physiol Regul Integr Comp Physiol
260:
R448-R452,
1991
30.
Rioux, KP,
Le T,
and
Swain MG.
Decreased orexigenic response to neuropeptide Y in rats with obstructive cholestasis.
Am J Physiol Gastrointest Liver Physiol
280:
G449-G456,
2001
31.
Ritter, S,
Bugarith K,
and
Dinh TT.
Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation.
J Comp Neurol
432:
197-216,
2001[Web of Science][Medline].
32.
Ritter, S,
Dinh TT,
Sanders NM,
and
Pedrow C.
Selective immunotoxin lesions of hypothalamically-projecting norepinephrine/epinephrine (Ne/E) neurons impairs the glucocorticoid response to glucoprivation.
Abstr Soc Neurosci
27 (947):
1,
2001.
33.
Ritter, S,
Dinh TT,
and
Zhang Y.
Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose.
Brain Res
856:
37-47,
2000[Web of Science][Medline].
34.
Ritter, S,
Llewellyn-Smith I,
and
Dinh TT.
Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge.
Brain Res
805:
41-54,
1998[Web of Science][Medline].
35.
Ritter, S,
Ritter JB,
and
Cromer L.
2-Deoxy-D-glucose and mercaptoacetate induce different patterns of macronutrient ingestion.
Physiol Behav
66:
709-715,
1999[Medline].
36.
Ritter, S,
and
Strang M.
Fourth ventricular alloxan injection causes feeding but not hyperglycemia in rats.
Brain Res
249:
198-201,
1982[Web of Science][Medline].
37.
Sahu, A,
Kalra PS,
and
Kalra SP.
Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus.
Peptides
9:
83-86,
1988[Web of Science][Medline].
38.
Salter, D,
and
Watts AG.
Glucoprivic feeding, but not other glucoregulatory responses, is attenuated in dehydration anorexia.
Abstr Soc Neurosci
27 (947):
7,
2001.
39.
Sanders, NM,
and
Ritter S.
Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation.
Diabetes
49:
1865-1874,
2000[Abstract].
40.
Sawchenko, PE,
Swanson LW,
Grzanna R,
Howe PR,
Bloom SR,
and
Polak JM.
Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus.
J Comp Neurol
241:
138-153,
1985[Web of Science][Medline].
41.
Scheurink, A,
and
Ritter S.
Sympathoadrenal responses to glucoprivation and lipoprivation in rats.
Physiol Behav
53:
995-1000,
1993[Medline].
42.
Shor-Posner, G,
Azar AP,
Insinga S,
and
Leibowitz SF.
Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions.
Physiol Behav
35:
883-890,
1985[Medline].
43.
Singer, LK,
and
Ritter S.
Differential effects of infused nutrients on 2-deoxy-D-glucose- and 2-mercaptoacetate-induced feeding.
Physiol Behav
56:
193-196,
1994[Medline].
44.
Solano, JM,
and
Jacobson L.
Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA.
Am J Physiol Endocrinol Metab
277:
E708-E716,
1999
45.
Stanley, BG,
and
Leibowitz SF.
Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus.
Life Sci
35:
2635-2642,
1984[Web of Science][Medline].
46.
Stanley, BG,
Magdalin W,
Seirafi A,
Thomas WJ,
and
Leibowitz SF.
The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s).
Brain Res
604:
304-317,
1993[Web of Science][Medline].
47.
Swanson, LW,
and
Hartman BK.
The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-
-hydroxylase as a marker.
J Comp Neurol
163:
467-506,
1975[Web of Science][Medline].
48.
Tanimura, SM,
Sanchez-Watts G,
and
Watts AG.
Peptide gene activation, secretion, and steroid feedback during stimulation of rat neuroendocrine corticotropin-releasing hormone neurons.
Endocrinology
139:
3822-3829,
1998
49.
Watson, PJ,
and
Biderman MD.
Failure of rats deprived of water to increase food intake during glucoprivation induced by 2-deoxy-D-glucose.
Pharmacol Biochem Behav
17:
955-959,
1982[Web of Science][Medline].
50.
Watts, AG.
Dehydration-associated anorexia: development and rapid reversal.
Physiol Behav
65:
871-878,
1999[Medline].
51.
Watts, AG.
Disturbance of fluid homeostasis leads to temporally and anatomically distinct responses in neuropeptide and tyrosine hydroxylase mRNA levels in the paraventricular and supraoptic nuclei of the rat.
Neuroscience
46:
859-879,
1992[Web of Science][Medline].
52.
Watts, AG.
Understanding the neural control of ingestive behaviors: helping to separate cause from effect with dehydration-associated anorexia.
Horm Behav
37:
261-283,
2000[Medline].
53.
Watts, AG,
Kelly AB,
and
Sanchez-Watts G.
Neuropeptides and thirst: the temporal response of corticotropin-releasing hormone and neurotensin/neuromedin N gene expression in rat limbic forebrain neurons to drinking hypertonic saline.
Behav Neurosci
109:
1146-1157,
1995[Web of Science][Medline].
54.
Watts, AG,
Sanchez-Watts G,
and
Kelly AB.
Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia.
J Neurosci
19:
6111-6121,
1999
55.
Weidenfeld, J,
Corcos AP,
Wohlman A,
and
Feldman S.
Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
Endocrinology
134:
1924-1931,
1994
56.
Yoshihara, T,
Honma S,
and
Honma K.
Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus.
Am J Physiol Endocrinol Metab
270:
E589-E595,
1996
57.
Zarjevski, N,
Cusin I,
Vettor R,
Rohner-Jeanrenaud F,
and
Jeanrenaud B.
Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
Endocrinology
133:
1753-1758,
1993
This article has been cited by other articles:
![]() |
D. Salter-Venzon and A. G. Watts Site-specific attenuation of food intake but not the latency to eat after hypothalamic injections of neuropeptide Y in dehydrated-anorexic rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1813 - R1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salter-Venzon and A. G. Watts The role of hypothalamic ingestive behavior controllers in generating dehydration anorexia: a Fos mapping study Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1009 - R1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Ross, M. Desai, C. Guerra, and S. Wang Prenatal programming of hypernatremia and hypertension in neonatal lambs Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R97 - R103. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |